One Health Studio:
Digital Twin of Human Pathophysiology
OneHealthStudio develops and utilizes mechanistic systems modeling enhanced by scientific machine learning to predict the impacts of chemicals, drugs, and pathogens on human (patho)physiology.
Our innovation accelerates life-science research and development by providing reliable predictions, thereby supporting decision-making while reducing reliance on animal testing.
Next Generation Risk Assessment
Next Generation Risk Assessment (NGRA) integrates computational, in-vitro and in-chemico approaches to evaluate chemical safety without animal testing.We
Model-Informed Drug Development
Model-Informed Drug Development (MIDD) uses quantitative models to inform drug development and regulatory decisions across all stages. We focus on model-based translational modeling in (pre-)clinical stages.
One Health
One Health acknowledges the connections between human, animal, and environmental health, encouraging cross-disciplinary collaboration to tackle complex health issues. Our innovative tools aims to serve for One Health risk assessment and One Health infection and preparedness applications.
choose a case study
Hover over organ for details.